| Financial Year |
March 31 2023 |
| Monetary Funds |
586,151,810.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
899,480,366.74 |
| Advances to Suppliers |
8,514,818.30 |
| Other Receivables |
22,815,984.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,730,359,955.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
82,023,596.94 |
| Total Current Assets |
3,365,872,383.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
35,276,371.73 |
| Investment Properties |
-- |
| Fixed Assetes |
193,821,961.59 |
| Under-construction Projects |
226,606,948.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
203,497,862.72 |
| R&D expenses |
51,856,263.96 |
| Goodwill |
289,783,575.09 |
| Long-Term Deferred and Prepaid Expenses |
5,567,000.71 |
| Deferred Income Tax Assets |
59,892,222.50 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,242,162,463.20 |
| Total Assets |
4,608,034,846.65 |
| Short-Term Loans |
288,824,614.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
505,174,775.92 |
| Accounts Payable |
475,910,340.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
66,859,777.37 |
| Taxes Payable |
27,965,218.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
53,667,518.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
82,719,977.72 |
| Other Current Liabilities |
291,637.17 |
| Sub-Total of Current Liabilities |
1,505,420,728.49 |
| Long-term Loans |
144,977,163.51 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,480,904.25 |
| Deferred Income Tax Liabilities |
18,348,114.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
254,547,992.81 |
| Total Liabilities |
1,759,968,721.30 |
| Paid-In Capital(Or Share Stock) |
606,304,981.00 |
| Capital Surplus |
807,582,095.86 |
| Surplus Reserve |
64,715,504.80 |
| LESS:Treasury Stock |
212,486.40 |
| Undistributed Profits |
684,456,223.22 |
| Minority Stockholder's Interest |
578,741,584.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,269,324,541.16 |
| Owner's Equity（Stockholder's Equity） |
2,848,066,125.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,608,034,846.65 |
